Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy.
Clinical trial NCT03704480 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03704480
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-09
- Primary completion
- 2022-07-28
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.